WO2019064082A3 - Pharmaceutical abuse deterrent composition constructed in more than one strengths - Google Patents

Pharmaceutical abuse deterrent composition constructed in more than one strengths Download PDF

Info

Publication number
WO2019064082A3
WO2019064082A3 PCT/IB2018/054443 IB2018054443W WO2019064082A3 WO 2019064082 A3 WO2019064082 A3 WO 2019064082A3 IB 2018054443 W IB2018054443 W IB 2018054443W WO 2019064082 A3 WO2019064082 A3 WO 2019064082A3
Authority
WO
WIPO (PCT)
Prior art keywords
strength
abuse deterrent
deterrent composition
strengths
pharmaceutical abuse
Prior art date
Application number
PCT/IB2018/054443
Other languages
French (fr)
Other versions
WO2019064082A2 (en
Inventor
Jayendrakumar Dasharathlal PATEL
Original Assignee
Patel Jayendrakumar Dasharathlal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Patel Jayendrakumar Dasharathlal filed Critical Patel Jayendrakumar Dasharathlal
Priority to US16/097,980 priority Critical patent/US20210046014A1/en
Publication of WO2019064082A2 publication Critical patent/WO2019064082A2/en
Publication of WO2019064082A3 publication Critical patent/WO2019064082A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

A pharmaceutical abuse deterrent composition and method of making the same is described in the present invention. A pharmaceutical abuse deterrent composition is constructed in one strength or more than one strength, wherein each strength in alone or in combination with another strength has a unique overdose prevention features. A pharmaceutical abuse deterrent composition is constructed in one strength or more than one strength, wherein each strength has resistant to physical tampering and chemical tampering.
PCT/IB2018/054443 2017-10-01 2018-06-16 Pharmaceutical abuse deterrent composition constructed in more than one strengths WO2019064082A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US16/097,980 US20210046014A1 (en) 2017-10-01 2018-06-16 Pharmaceutical abuse deterrent composition constructed in more than one strengths

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN201721034838 2017-10-01
IN201721034838 2017-10-01

Publications (2)

Publication Number Publication Date
WO2019064082A2 WO2019064082A2 (en) 2019-04-04
WO2019064082A3 true WO2019064082A3 (en) 2020-02-06

Family

ID=65902706

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2018/054443 WO2019064082A2 (en) 2017-10-01 2018-06-16 Pharmaceutical abuse deterrent composition constructed in more than one strengths

Country Status (1)

Country Link
WO (1) WO2019064082A2 (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010088911A1 (en) * 2009-02-06 2010-08-12 Egalet A/S Pharmaceutical compositions resistant to abuse
WO2017059374A1 (en) * 2015-09-30 2017-04-06 Kashiv Pharma Llc Overdose protection and abuse deterrent immediate release drug formulation
US20170157055A1 (en) * 2014-09-27 2017-06-08 Jayendrakumar Dasharathlal Patel Pharmaceutical abuse deterrent composition

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010088911A1 (en) * 2009-02-06 2010-08-12 Egalet A/S Pharmaceutical compositions resistant to abuse
US20170157055A1 (en) * 2014-09-27 2017-06-08 Jayendrakumar Dasharathlal Patel Pharmaceutical abuse deterrent composition
WO2017059374A1 (en) * 2015-09-30 2017-04-06 Kashiv Pharma Llc Overdose protection and abuse deterrent immediate release drug formulation

Also Published As

Publication number Publication date
WO2019064082A2 (en) 2019-04-04

Similar Documents

Publication Publication Date Title
WO2017041134A8 (en) Highly chemical resistant glove
WO2016100374A3 (en) Tough and wear resistant ferrous alloys containing multiple hardphases
EP3914259A4 (en) Rna-editing oligonucleotides and uses thereof
WO2017178653A3 (en) NEW ANTI-SIRPa ANTIBODIES AND THEIR THERAPEUTIC APPLICATIONS
CA167477S (en) Dispenser
CA167479S (en) Dispenser
WO2017181098A3 (en) Antibody molecules to zika virus and uses thereof
CA167484S (en) Dispenser
CA167493S (en) Dispenser
WO2017123748A8 (en) Thermostable variants of t7 rna polymerase
CA167480S (en) Dispenser
EP3334446A4 (en) Engineered outer domain (eod) of hiv gp120, mutants and use thereof
WO2016071503A8 (en) Phage therapy
PL3719148T3 (en) High-hardness steel product and method of manufacturing the same
MY174368A (en) Sanitary product and agent for treating sanitary product
HK1212488A1 (en) Intelligent electronic lock keyboard and method of unlocking the same, and intelligent electronic lock
PH12018500857A1 (en) Multilayer composition and process of making
WO2015153501A3 (en) Modified santalene synthase polypeptides, encoding nucleic acid molecules and uses thereof
WO2015148768A3 (en) Onconase for use in treating or preventing viral infections
CA162444S (en) Fork
CA3063204A1 (en) Clotting factor variants and their use
FR3044663B1 (en) MONOFUNCTIONAL OR TELECHELIC COPOLYMER OF 1,3-BUTADIENE AND ETHYLENE
WO2019064082A3 (en) Pharmaceutical abuse deterrent composition constructed in more than one strengths
WO2017081692A3 (en) Biocompatible articles with embedded copper ions and copper ion releasing coating
ZA201806768B (en) Ring-fused thiazolino 2-pyridones, methods for preparation thereof and their use in the treatment and/or prevention of tuberculosis

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 18862647

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 18862647

Country of ref document: EP

Kind code of ref document: A2